cisplatin,erdafitinib,cetrelimab
janssen
['urothelial carcinoma', 'cisplatin', 'urothelial', 'congrat']
outstanding discussion by at #asco2023 highlighting the developments in the treatment landscape for advanced cisplatin-ineligible urothelial carcinoma. congrats! 
Medical Oncologist | Vice Chancellor for Research @CUAnschutz @CUDenver | #BladderCancer #ProstateCancer Research